The VitalScan Device From Creavo Medical Technologies For The Detection Of Heart Disease In A Patient
Over a five percent of the medical patients visit the accident and emergency department. About 40 percent of the cases are related to chest pain. All those people with chest pain had to stay up to 20 hours at the hospitals to undergo tests (expensive) related to heart disease. But about 75 percent of those cases found not to be with any serious heart disease.
The researchers from the Creavo Medical Technologies, the United Kingdom, have developed a battery operated and portable VitalScan device. The device can read, display and store electromagnetic variations of the heart (cardiac). The product can perform a quick scan (within five minutes) for signs of heart diseases in a patient and can save time and healthcare costs.
This innovative device uses the "Disease Detection Technology", "Magnetocardiography (MCG) Technology", and an algorithm (for noise reduction) to map (scan) the magnetic fields of the extremely small electrical signals (impulses) of the heart. Even a slight disruption in the function of the heart caused due to heart disease (example: ischaemic heart disease) will distort the magnetic field of the heart. The distortions in the magnetic field of the heart can be seen clearly in the scan (map) of this device.
This device helps the heart specialists in identifying heart disease accurately and quickly in a patient. The patient can save time and money. The patient can get an appropriate treatment quickly. The clinical trial of this non-invasive device is being conducted in the United Kingdom. The United States Food and Drug Administration has approved the clinical trial in the United States. The device is going to be tested in emergency departments in the United States.
Women Are At An Enhanced Risk Of Death In The First Year After The Heart Attack
About two-thirds of patients admitted to the hospital after the heart attack are men. But women suffer from a different type of heart attack. Women are at a higher risk of death (mortality) within a year after suffering a heart attack.
This is because women suffer from the diffuse coronary artery disease (widespread disease or damage in the coronary arteries) and the surgical procedures may not be successful. Female patient with a heart attack also likely to be a patient of diabetes.
The average age of a female patient with a heart attack is ten years higher compared to the average age of a male patient with a heart attack. Another important and likely risk factor for women in addition to diabetes is depression.
A study at the Technical University of Munich (TUM), Germany shows an enhanced risk of death (mortality) in women compared to men during the first year after surviving a heart attack.
Researchers have analyzed data of nearly 4,100 participants. The researchers have found 1.5 times higher risk of death within 365 days after having a heart attack in women compared to men with similar heart disease history.
The author of the study was Professor Georg Schmidt, a cardiologist and also Head of Biosignal Analysis Working Group, Technical University of Munich (TUM), Germany. The study was published on October 20, 2017, in the journal PLOS ONE.
Citation: Ubrich R, Barthel P, Haller B, Hnatkova K, Huster KM, Steger A, et al. (2017) Sex differences in long-term mortality among acute myocardial infarction patients: Results from the ISAR-RISK and ART studies. PLoS ONE 12(10): e0186783.
The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. The published article is not a medical advice by the OWNER of the "Diabetes News Chronicle" website or by the AUTHOR of the article.
Published by Jammi Vasista, Chennai, India.